UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000004583
Receipt No. R000005475
Official scientific title of the study Clinical study to investigate recurrence efficacy on a combined use of radiofrequency ablation therapy and auto-gamma/delta T cell therapy for hepatitis C virus-related hepatocellular carcinoma patients.
Date of disclosure of the study information 2010/11/18
Last modified on 2018/04/19 (Ver. 9)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Clinical study to investigate recurrence efficacy on a combined use of radiofrequency ablation therapy and auto-gamma/delta T cell therapy for hepatitis C virus-related hepatocellular carcinoma patients.
Title of the study (Brief title) Clinical study to investigate recurrence efficacy on a combined use of radiofrequency ablation therapy and auto-gamma/delta T cell therapy for hepatitis C virus-related hepatocellular carcinoma patients.
Region
Japan

Condition
Condition Hepatitis C virus-related hepatocellular carcinoma
Classification by specialty
Hepato-biliary-pancreatic medicine
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To investigate efficacy on combination therapy of radiofrequency ablation therapy and auto-gamma/delta T cell therapy for hepatitis C virus-related hepatocellular carcinoma
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Recurrence-free survival rate
Key secondary outcomes Recurrence-free survival
Overall survival
Disease-specific survival
Immunological responses
Safety

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 Auto-gamma/delta T cell therapy repeats 6 times every 2 weeks.
Two days after first auto-gamma/delta T cell therapy, patients receive radiofrequency ablation therapy.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
75 years-old >=
Gender Male and Female
Key inclusion criteria Hepatitis C virus-related hepatocellular carcinoma patients who meet the following:
- 3 or fewer lesions, and each maximum diameter 3cm or less;
- Child-Pugh score 5-7;
- Performance status 0-1;
- No serious abnormality in heart, lung, bone marrow, liver, and renal functions.
Key exclusion criteria Patients who have:
- Active enteritis;
- Active autoimmune diseases;
- Active infections;
- Other cancers;
- Other serious complications;
- Continuous systemic administration of steroids.
Target sample size 40

Research contact person
Name of lead principal investigator Fuminori Moriyasu
Organization Tokyo Medical University
Division name Fourth Department of Internal Medicine
Address 6-7-1, Nishishinjyuku, Shinjyuku-ku, Tokyo, Japan
TEL
Email

Public contact
Name of contact person
Organization Tokyo Medical University
Division name Fourth Department of Internal Medicine
Address 6-7-1, Nishishinjyuku, Shinjyuku-ku, Tokyo, Japan
TEL
Homepage URL
Email

Sponsor
Institute Tokyo Medical University
Institute
Department

Funding Source
Organization Medinet Co.,Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor Seta Clinic Group
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東京医科大学病院(東京都)、瀬田クリニック東京(東京都)、瀬田クリニック新横浜(神奈川県)

Other administrative information
Date of disclosure of the study information
2010 Year 11 Month 18 Day

Progress
Recruitment status Completed
Date of protocol fixation
2010 Year 09 Month 29 Day
Anticipated trial start date
2010 Year 11 Month 01 Day
Last follow-up date
2015 Year 11 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2010 Year 11 Month 18 Day
Last modified on
2018 Year 04 Month 19 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005475